Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05144191 · ClinicalTrials.gov registry record · NA
Insignia™ Hip Stem Outcomes Study
A NA study of Rheumatoid Arthritis and Surgery, sponsored by Stryker Orthopaedics.
- Active
- Registry status
- NA
- Development phase
- 313
- Enrollment target
- 11
- Study locations
NCT05144191: Active NA study of Rheumatoid Arthritis and Surgery, sponsored by Stryker Orthopaedics.
NCT05144191 is a NA study of Rheumatoid Arthritis and Surgery that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 313 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05144191, a NA study of Rheumatoid Arthritis and Surgery, is active but no longer recruiting, sponsored by Stryker Orthopaedics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 313 participants
- Enrollment target
- 11
- Study locations
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
Primary Outcome
Evaluation of the survival rate for Insignia Hip Stem is defined as absence of femoral stem revision for aseptic loosening or device-related femoral fracture.
Conditions Studied
Interventions
- DEVICE Insignia uncemented Hip Stem
Study Locations (11)
Washington
- Orthopedic Physician Associates - Seattle
- Providence Orthopedics and Sports Medicine - Spokane
Arizona
- The MORE Foundation - Phoenix
California
- University of California, San Francisco - San Francisco
Illinois
- Midwest Orthopaedics at Rush - Chicago
Nevada
- Reno Orthopedic Center Foundation - Reno
New York
- Northwell Health: University Orthopaedic Associates - Great Neck
North Carolina
- OrthoCarolina Research Institute - Charlotte
Pennsylvania
- Alleghany Health Network- Research Institute - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2022-02-07 |
| Est. Completion | 2034-04-02 |
| Phase | NA |
What the registry record for NCT05144191 still lists
NCT05144191 is an interventional study that assigns participants to a tested intervention. The registered 313 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower).
The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Insignia uncemented Hip Stem is the first listed.
NCT05144191 lists 11 locations in 10 states (Washington, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT05144191 about?
NCT05144191 is a clinical study titled "Insignia™ Hip Stem Outcomes Study". The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
What is the current status of trial NCT05144191?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 313 participants. The study started on 2022-02-07. Estimated completion is 2034-04-02.
What conditions does trial NCT05144191 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Surgery, Avascular Necrosis, Hip Osteoarthritis, Post-traumatic Osteoarthritis.
What interventions are being tested in trial NCT05144191?
The interventions under investigation include: Insignia uncemented Hip Stem (DEVICE).
Who is sponsoring clinical trial NCT05144191?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05144191 being conducted?
This trial has 11 study locations across Arizona, California, Illinois, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05144191's enrollment target sits among peer trials
313 57th of 197 higher than 141 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00595491 · 313 participants · Phase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI